# TENOFOVIR DISOPROXIL FUMARATE
> **ANDA211337** · Abbreviated New Drug Application (Generic) · Sponsor: REYOUNG · Approved 2023-03-02
## Drug
- **FDA Application Number:** ANDA211337
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TENOFOVIR DISOPROXIL FUMARATE
- **Generic name:** Tenofovir Disoproxil Fumarate
- **Active ingredients:** TENOFOVIR DISOPROXIL FUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** REYOUNG
- **First approval:** 2023-03-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211337)
---
*AI Analytics · CC0 1.0*